Cargando…

Circulating Cell-Free DNA in Plasma of Locally Advanced Rectal Cancer Patients Undergoing Preoperative Chemoradiation: A Potential Diagnostic Tool for Therapy Monitoring

Circulating cell-free DNA opens up an interesting field for therapy monitoring, in particular during multimodal therapy protocols. The objective of this proof of principle study was to evaluate whether the amount of circulating plasma DNA has the potential to serve as a marker for therapy monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zitt, Matthias, Müller, Hannes M., Rochel, Marina, Schwendinger, Verena, Zitt, Marion, Goebel, Georg, DeVries, Alexander, Margreiter, Raimund, Oberwalder, Michael, Zeillinger, Robert, Öfner, Dietmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2008
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827809/ https://www.ncbi.nlm.nih.gov/pubmed/19096128 http://dx.doi.org/10.1155/2008/598071

Ejemplares similares

Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias
por: Goebel, Georg, et al.
Publicado: (2005)

Dickkopf-3 As a New Potential Marker for Neoangiogenesis in Colorectal Cancer: Expression in Cancer Tissue and Adjacent Non-Cancerous Tissue
por: Zitt, Matthias, et al.
Publicado: (2008)

14-3-3 Sigma And p53 Expression in Gastric Cancer and Its Clinical Applications
por: Mühlmann, Gilbert, et al.
Publicado: (2010)

DNA Methylation in Colorectal cancer—Impact on Screening and Therapy Monitoring Modalities?
por: Zitt, Marion, et al.
Publicado: (2007)

Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer: Impact on long-term outcome. Results of the phase II TAKO 05/ABCSG R‑02 trial
por: Kogler, P., et al.
Publicado: (2017)

Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria
por: Pamela, Kogler, et al.
Publicado: (2018)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety
por: Peponi, Evangelia, et al.
Publicado: (2015)

Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
por: Restivo, Angelo, et al.
Publicado: (2015)

Prospectively Randomized Controlled Trial on Damage Control Surgery for Perforated Diverticulitis with Generalized Peritonitis
por: Kafka-Ritsch, Reinhold, et al.
Publicado: (2020)

Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report
por: Bösmüller, Claudia, et al.
Publicado: (2019)

Preoperative MRI accuracy after neoadjuvant chemoradiation for locally advanced rectal cancer
por: Popiţa, Anca-Raluca, et al.
Publicado: (2023)

Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation
por: Wan, Juefeng, et al.
Publicado: (2015)

Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer
por: Lee, Yong Joon, et al.
Publicado: (2016)

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation
por: Han, Yoon Dae, et al.
Publicado: (2015)

Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
por: Glynne-Jones, R, et al.
Publicado: (2006)

Prognostic Significance of Serum Carcinoembryonic Antigen Normalization on Survival in Rectal Cancer Treated with Preoperative Chemoradiation
por: Chung, Mi-Joo, et al.
Publicado: (2013)

Immunohistochemical Detection of p53 Expression in Patients with Preoperative Chemoradiation for Rectal Cancer: Association with Prognosis
por: Huh, Jung Wook, et al.
Publicado: (2015)

Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules
por: Park, Shin-Hyung, et al.
Publicado: (2016)

Five-year outcomes of preoperative chemoradiation for rectal carcinoma in Saudi population: single-institutional experience
por: AlSaeed, Eyad Fawzi, et al.
Publicado: (2015)

MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation
por: Chen, Haihui, et al.
Publicado: (2020)

A universal cell‐free DNA approach for response prediction to preoperative chemoradiation in rectal cancer
por: Grinshpun, Albert, et al.
Publicado: (2022)

Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy
por: Friedl, Claudia, et al.
Publicado: (2018)

Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
por: Friedl, Claudia, et al.
Publicado: (2017)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: A Comparison of Bolus 5-Fluorouracil/Leucovorin and Capecitabine
por: Yoney, Adnan, et al.
Publicado: (2014)

Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer
por: Han, Kyung Su, et al.
Publicado: (2016)

Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer
por: Kim, Ik Yong, et al.
Publicado: (2014)

New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer
por: Kim, Nam Kyu, et al.
Publicado: (2015)

The Krüppel-like factor (KLF5) as a predictive biomarker in preoperative chemoradiation therapy for rectal cancer
por: Kim, Jeong Yeon, et al.
Publicado: (2019)

Can lymphocytes serve as a predictor of response to preoperative chemoradiation therapy for locally advanced rectal cancer?
por: Lutsyk, Myroslav, et al.
Publicado: (2023)

Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
por: Dickman, Ram, et al.
Publicado: (2013)

Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation
por: Huh, Jung Wook, et al.
Publicado: (2016)

The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer
por: Han, Jeonghee, et al.
Publicado: (2016)

Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
por: Gollins, Simon, et al.
Publicado: (2017)

High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers
por: Lin, Shih-Chun, et al.
Publicado: (2017)

Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not.
por: Socha, J., et al.
Publicado: (2023)

Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry
por: Steurer, Michael, et al.
Publicado: (2008)

Change of telomerase activity in rectal cancer with chemoradiation therapy.
por: Kim, H. R., et al.
Publicado: (2000)

Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
por: Conde-Muíño, Raquel, et al.
Publicado: (2015)

Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bpmush8e8paa9e9qi2o00mp4lp